Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Dec 15.
Published in final edited form as: J Neurol Sci. 2022 Nov 8;443:120489. doi: 10.1016/j.jns.2022.120489

Secondhand Smoke Exposure is independently associated with Stroke among non-smoking Adults in West Africa

Akinkunmi Paul Okekunle 1,2, Osahon Jeffery Asowata 3, Adekunle G Fakunle 1,4, Onoja Matthew Akpa 3,5, Fred S Sarfo 6, Albert Akpalu 7, Kolawole Wahab 8, Reginald Obiako 9, Morenikeji Komolafe 10, Lukman Owolabi 11, Godwin O Osaigbovo 12, Hemant K Tiwari 13, Joshua Akinyemi 3, Carolyn Jenkins 14, Oyedunni Arulogun 15, Philip Ibinaiye 9, Lambert Appiah 6, Atinuke M Agunloye 1, Abiodun M Adeoye 1, Joseph Yaria 1, Benedict Calys-Tagoe 7, Ezinne O Uvere 1, Godwin Ogbole 16, Francis Agyekum 6, Taofeek A Sanni 17, Amusa G Adeniyi 12, Mayowa Ogunronbi 18, Samuel Olowookere 18, Olayemi Balogun 9, Ayo J Ogunmodede 8, Oladotun Olalusi 1, Diala Samuel 1, Aliyu Mande 11, Musbahu Rabiu 11, Philip Adebayo 19, Adeniyi Sunday 8, Lucius Chidiebere Imoh 12, Ayodipupo Oguntade 1, Abiodun Ajose 1, Arti Singh 6, Oluwayemisi T Adeegbe 1, Yaw Mensah 6, Bimbo Fawale 10, Salaam Abdul 12, Joyce Ikubor 12, Afolaranmi Tolulope 12, Isah S Yahaya 11, Cynthia Akisanya 18, Chidi J Odo 16, Richard Efidi 16, Innocent I Chukwuonye 20, Vincent Shidali 9, Akintunde Adebowale 10, Kenneth A Ohagwu 20, Osimhiarherhuo O Adeleye 18, Henry Iheonye 21, Adeseye Akintunde 22, Eunice Olabiri 17, Josephine Akpalu 7, Julius Adesina 18, Ugochukwu Onyeonoro 20, Akinola Onasanya 18, Donna K Arnett 23, Daniel Lackland 24, Rufus Akinyemi 18,25, Bruce Ovbiagele 26, Mayowa Owolabi 1,25,, on behalf of SIREN
PMCID: PMC9712270  NIHMSID: NIHMS1850770  PMID: 36399928

Abstract

Background:

Stroke is a leading cause of disability and mortality worldwide, but little is known about the contribution of secondhand smoke exposure (SHSE) to stroke epidemiology among indigenous Africans.

Objective:

To evaluate the association of SHSE with stroke among indigenous Africans.

Methods:

We analyzed the relationship of SHSE with stroke among 2,990 case-control pairs of adults who had never smoked (identified in the SIREN study) using conditional logistic regression at a two-sided P<0.05.

Results:

Multivariable-adjusted odds ratio and 95% confidence interval; 1.25 (1.04, 1.50; P=0.02) revealed SHSE was positively associated with stroke independent of stroke subtypes.

Conclusion:

Culturally relevant primary prevention strategies targeted at SHSE might be promising in preventing stroke among Africans.

Keywords: Secondhand smoking, Stroke, Haemorrhagic stroke, Ischaemic stroke, SIREN

1.0. Introduction

Stroke is one of the most significant causes of disability and mortality worldwide1,2, including among Africans3,4. Several studies have highlighted the significance of secondhand smoke exposure (SHSE) in vascular events58, but this relationship is yet to be established among Africans. Characterizing the relationship between SHSE and stroke among Africans is likely to facilitate the design of culturally-relevant public health guidelines for mitigating the impact of SHSE on the burden of stroke among Africans. This study assessed the association of SHSE with stroke among West Africans from Ghana and Nigeria who had never smoked or used any form of tobacco product in their lifetime.

2.0. Materials and Methods

All respondents in the current study had never smoked or used any form of tobacco. For this present report, we identified adults (≥ 18 years); 2,990 stroke case-control pairs matched for age (+/− 5 years), sex and ethnicity in the Stroke Investigation Research and Educational Network (SIREN) study. Standardized instruments were administered to collect data on sociodemographic and lifestyle factors, anthropometry, and clinical examinations by skilled medical practitioners and trained personnel3,9. SHSE definition in this study was adapted from the self-report validated method suggested by the National Health Nutrition Examination Survey10. It was defined as self-reported exposure to smoke from a burning cigarette or exhaled from a smoker in any indoor area at least once a week in the last 12 months preceding the study or before the onset of stroke. Stroke was defined based on clinical evaluation and brain neuroimaging (computerized tomography or magnetic resonance imaging); electrocardiogram, transthoracic echocardiography, and carotid Doppler ultrasound were carried out using standard operating procedures at each hospital site3. Controls were stroke-free adults validated and recruited from catchment communities around the study hospitals where stroke cases reside11. Respondents’ characteristics were compared between stroke cases and stroke-free controls using McNemar’s test for categorical data and a paired t-test for continuous data. Besides the matching for age, sex, and ethnicity, stepwise conditional regression models were used to estimate the adjusted odds ratio (OR) and 95% confidence interval (CI) for the risk of stroke by SHSE status, adjusting for the highest education completed, monthly income, alcohol use, physical inactivity, obesity, diabetes mellitus, systolic and diastolic blood pressures and dyslipidaemia. Similarly, we conducted subgroup analyses by stroke status (ischaemic or haemorrhagic), sex (female or male), age group (<60years or ≥60years) and country (Ghana or Nigeria). Test of interaction was conducted using a likelihood ratio test. All statistical analyses were carried out using IBM SPSS Statistics for Windows, version 21 (IBM Corporation, Armonk, NY USA) and R statistical program (version 3.6.2) at a two-sided P<0.05.

3.0. Results

Stroke cases had higher rates of higher education and higher income than stroke-free controls (Table 1). Similarly, stroke cases had higher blood pressure profiles, with higher rates of physical inactivity, family history of cardiovascular diseases (CVD), abdominal obesity, DM and dyslipidemia than stroke-free controls. Overall (Figure 1a), 19.5% of the entire sample had experienced SHSE. SHSE was more prevalent among stroke cases than among stroke-free controls (Figure 1b), but this difference was statistically insignificant (20.5% vs 18.5%, P < 0.01). There were significant differences based on stroke type (haemorrhagic stroke 23.9% vs ischemic stroke 19.2% P < 0.01, Figure 1c), sex (females 17.3% vs males 21.9%, P < 0.01, Figure 1d), age groups (<60 years 22.3% vs ≥60 years 16.8%, P < 0.01, Figure 1e) and country of residence (Ghana 15.3% vs Nigeria 21.5%, P < 0.01, Figure 1f).

Table 1:

Characteristics of all non-active smokers stratified by stroke status in the SIREN Study

Stroke status
Characteristics Stroke-free controls (n=2990) Stroke Cases (n=2990) P-value
Country
Ghana 970 (32.4) 913 (30.5)
Nigeria 2020 (67.6) 2077 (69.5)
Sex
Females 1561 (52.2) 1561 (52.2)
Males 1429 (47.8) 1429 (47.8)
Age (years), mean ± SD 58.24±14.08 59.23±12.20
<60years 1505 (50.3) 1469 (49.1) 0.78
≥60years 1485 (49.7) 1521 (50.9)
Education
None 706 (23.6) 599 (20.0) <0.01
Primary school 746 (24.9) 603 (20.2)
Secondary school and above 1538 (51.4) 1788 (59.8)
Monthly Income
< $100 1858 (62.1) 1416 (47.4) <0.01
≥ $100 1132 (37.9) 1574 (52.6)
Lifestyle factors
Ever alcohol use (Yes) 687 (23.0) 745 (24.9) 0.08
Family history of CVD 718 (24.0) 1078 (36.1) <0.01
Physical inactivity 79 (2.6) 116 (3.9) 0.01
WHR, mean ± SD 0.91±0.08 0.94±0.08 <0.01
WHR ≥ 0.90 (men) & 0.85 (women) 2107 (70.5) 2514 (84.1) <0.01
BMI (kg/m2), mean ± SD 26.31±5.74 26.83±5.34 <0.01
BMI ≥ 30kg/m2 662 (22.1) 659 (22.0) 0.93
SBP (mmHg), mean ± SD 137.37±24.44 158.80±31.06 <0.01
DBP (mmHg), mean ± SD 83.03±14.40 95.45±18.32 <0.01
Diabetes (Yes) 333 (11.1) 1140 (38.1) <0.01
Dyslipidemia (Yes) 1688 (56.5) 2471 (82.6) <0.01

Continuous data are presented as mean ± standard deviation and compared using the t-test;

Categorical data are presented as n (%) and compared using the McNemar test

Figure 1:

Figure 1:

Prevalence of SHSE in the entire sample (a), among cases and controls (b), stratified by stroke subtypes (c), sex (d), age groups (e) and country of residence (f) of respondents in the SIREN population.

Proportion of those with SHSE between the two groups was statistically different (P < 0.05).

SHSE was independently associated with higher odds of stroke after adjusting for multiple covariates (Figure 2); OR: 1.25, 95% CI: 1.04, 1.50; P = 0.02. The association remained when stratified by stroke subtypes, haemorrhagic stroke; OR: 1.53, 95% CI: 1.07, 2.18; P = 0.02, but was statistical insignificant for ischaemic stroke; OR: 1.14, 95% CI: 0.91, 1.42; P = 0.24, (P for Interaction = 0.05). Also, SHSE was associated with higher odds of stroke among males, OR: 1.41, 95% CI: 1.07, 1.84; P = 0.01, but not among females, OR: 1.09, 95% CI: 0.84, 1.42; P = 0.49, (P for Interaction = 0.29). Similarly, SHSE was associated with higher odds of stroke among ≥60 years, OR: 1.33, 95% CI: 1.02, 1.75; P = 0.04, but not among <60 years, OR: 1.16, 95% CI: 0.88, 1.53; P = 0.28, (P for Interaction = 0.29). In the country-stratified analyses, we observed higher stroke odds among respondents from Ghana, OR: 1.45, 95% CI: 1.02, 2.04; P = 0.04, but not among those in Nigeria, OR: 1.01, 95% CI: 0.79, 1.28; P = 0.92, (P for Interaction < 0.01).

Figure 2:

Figure 2:

Full model of the conditional logistic regression adjusting for highest education completed (none, primary school and above), monthly income (<$100, ≥$100), ever used alcohol (no, yes), physical Inactivity (no, yes), obesity (<30kg/m2, ≥ 30kg/m2), diabetes (no, yes), SBP (in mmHg, continuous), DBP (in mmHg, continuous) and dyslipidaemia (no, yes).

4.0. Discussion

This study tested the relationship between SHSE and stroke among indigenous West Africans who had never smoked in a lifetime and found SHSE was independently associated with the risk of all stroke events in a relationship driven by haemorrhagic strokes. To our understanding, our study is the first to test the relationship between SHSE and stroke in an indigenous African population. The significance of our findings cannot be underestimated in designing culturally relevant primary prevention strategies for stroke and CVD management among African populations. Some reports have documented the significance of active smoking in the epidemiology of CVD events12,13, with limited evidence alluding to the implications of SHSE in stroke outcomes, especially among never smokers. Our findings mirrored conclusions from earlier observational studies58. For example, a population-based, longitudinal study in the United States found that SHSE accounted for a 30% increase in the overall risk of stroke5. Another longitudinal study in Britain reported a raised risk of myocardial infarction among never-smokers who lived with a smoker14. Similarly, two separate meta-analyses observed that SHSE was positively related to the risk of stroke6,15.

Furthermore, SHSE has been linked with cognitive dysfunction6, depressive symptoms16, hypertension17, impaired lipid metabolism18 and heart failure19. Contrary to earlier reports58, our study found a statistically insignificant positive association between SHSE and ischaemic stroke. This observation is likely driven by difference(s) in study design, SHSE assessment or perhaps statistically underpowered to detect an association rather than physiologic differences across populations. Also, our results revealed no evidence of interaction for the results by stroke subtypes, sex, or age group, but not by country of residence. Similarly, the interaction by country is unlikely due to racial, regional or environmental differences, but the degree of SHSE exposure might differ in both countries. Our study did not assess the magnitude of SHSE, which might be a reason for the absence of the statistically significant association between SHS and ischemic stroke. The impact of SHSE on stroke events may be attributable to the apparent effect of smoke exposure on stroke and CVD outcome8,12,13. Similarly, SHSE has been linked to vascular dysfunction20,21. Also, nicotine is a principal constituent of smoke with a potential pharmacologic consequence that could induce the sympathetic nervous system to release catecholamines22, which has been linked to the aggravated collapse of the blood-brain barrier and, consequently, severe stroke23. SHSE is a proxy for vulnerability to deprived living conditions24 unconsidered in this study. Perhaps our findings offer insight into the significance of living conditions, quality of life and other unmeasured proximal and distal factors among Africans likely to be critical in stroke epidemiology and care. Still, public health interventions might be necessary to protect vulnerable populations from SHSE to reduce the snowballing burden of stroke and CVD among Africans.

There are some limitations in this study worth mentioning. First, nicotine measurement is the gold standard for validating SHSE and using self-reports might be subjective and very likely to underestimate the actual exposure. We did not determine the degree of SHSE, which would have better described the association between SHSE and stroke. Second, cognitive impairment might likely bias responses from older respondents, particularly after stroke, but key informants were at hand to validate/offer pertinent information on behalf of respondents where required. The study’s strength includes the physician-adjudicated stroke definition, the large sample size, the multi-country sampling approach, the multivariate adjustment for potential confounders based on the clinical understanding of stroke and being the first to report these findings in an indigenous African population. Future longitudinal studies should consider discerning the magnitude and duration of SHSE among Africans.

5.0. Conclusion

Habitual exposure to SHSE may likely promote stroke risk among West Africans. Culturally relevant interventions such as public health education and policies targeted at managing SHSE might be necessary for the primary prevention of stroke among indigenous Africans.

Highlights.

  • SHSE is associated with the risk of stroke among Africans.

  • Profiling SHSE might be promising in estimating the overall significance of smoke exposure in stroke epidemiology

  • Public health interventions are necessary to protect vulnerable populations from SHSE.

Acknowledgement

The authors would like to thank all respondents from Ghana and Nigeria who volunteered to participate in this study.

Funding

The study and investigators are supported by the National Institutes of Health grants SIREN (U54HG007479), SIBS Genomics (R01NS107900), African Neurobiobank for Precision Stroke Medicine (U01HG010273), SIBS Gen Gen (R01NS107900-02S1), ARISES (R01NS115944-01), H3Africa CVD Supplement (3U24HG009780-03S5), CaNVAS (1R01NS114045-01), SSACS (1R13NS115395-01A1) and TALENTS (D43TW012030). APO is a recipient of the Brain Pool Fellowship of the National Research Foundation of Korea (2020H1D3A1A04081265). The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Footnotes

Publisher's Disclaimer: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Statements and Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The SIREN study was a multi-centre case-control study among West Africans from Nigeria and Ghana. The overall coordinating Institutional Review Board (IRB) for the SIREN study was the University of Ibadan/University College Hospital Ibadan, Nigeria (UI/EC/13/0105). IRB at all study sites approved the study, and all respondents provided written informed consent before participation in the study.

References

  • 1.Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67–e492. [DOI] [PubMed] [Google Scholar]
  • 2.Kim J, Thayabaranathan T, Donnan GA, et al. Global Stroke Statistics 2019. Int J Stroke. 2020;15(8):819–838. [DOI] [PubMed] [Google Scholar]
  • 3.Owolabi MO, Sarfo F, Akinyemi R, et al. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. The Lancet Global Health. 2018;6(4):e436–e446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Akinyemi RO, Ovbiagele B, Adeniji OA, et al. Stroke in Africa: profile, progress, prospects and priorities. Nature Reviews Neurology. 2021;17(10):634–656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Malek AM, Cushman M, Lackland DT, Howard G, McClure LA. Secondhand Smoke Exposure and Stroke: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Prev Med. 2015;49(6):e89–e97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liu W, Wang B, Xiao Y, Wang D, Chen W. Secondhand smoking and neurological disease: a meta-analysis of cohort studies. Rev Environ Health. 2021;36(2):271–277. [DOI] [PubMed] [Google Scholar]
  • 7.Pistilli M, Howard VJ, Safford MM, et al. Association of secondhand tobacco smoke exposure during childhood on adult cardiovascular disease risk among never-smokers. Ann Epidemiol. 2019;32:28–34.e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Parikh NS, Chatterjee A, Díaz I, et al. Trends in Active Cigarette Smoking Among Stroke Survivors in the United States, 1999 to 2018. Stroke. 2020;51(6):1656–1661. [DOI] [PubMed] [Google Scholar]
  • 9.Akpalu A, Sarfo FS, Ovbiagele B, et al. Phenotyping Stroke in Sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) Phenomics Protocol. Neuroepidemiology. 2015;45(2):73–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.NHANES. Smoking and Tobacco Use – SMQ. Centre for Disease Control. 2013–2014 Data Documentation Codebook, and Frequencies Web site. https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2013. Published 2013. Updated 09.2019. Accessed 12.08.2020, 2020.
  • 11.Sarfo F, Gebregziabher M, Ovbiagele B, et al. Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa. Stroke. 2016;47(1):167–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Reitsma MB, Fullman N, Ng M, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017;389(10082):1885–1906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Noubiap JJ, Nansseu JR, Endomba FT, et al. Active smoking among people with diabetes mellitus or hypertension in Africa: a systematic review and meta-analysis. Sci Rep. 2019;9(1):588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jefferis BJ, Lawlor DA, Ebrahim S, et al. Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults. Heart. 2010;96(11):854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: A meta-analysis. Medicine. 2019;98(12):e14872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Okekunle AP, Asowata JO, Lee JE, Akpa OM. Association of Environmental tobacco smoke exposure with depression among non-smoking adults. BMC Public Health. 2021;21(1):1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Akpa OM, Okekunle AP, Asowata JO, Adedokun B. Passive smoking exposure and the risk of hypertension among non-smoking adults: the 2015–2016 NHANES data. Clinical Hypertension. 2021;27(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Okekunle AP, Asowata JO, Adedokun B, Akpa OM. Secondhand smoke exposure and dyslipidemia among non-smoking adults in the United States. Indoor Air. 2021;n/a(n/a). [DOI] [PubMed] [Google Scholar]
  • 19.Skipina TM, Upadhya B, Soliman EZ. Secondhand Smoke Exposure is Associated with Prevalent Heart Failure: Longitudinal Examination of the National Health and Nutrition Examination Survey. Nicotine Tobacco Res. 2021. [DOI] [PubMed] [Google Scholar]
  • 20.Shi J, Bai Y, Qiu S, et al. Classified status of smoking and quitting has different associations with dyslipidemia in residents in northeast China. Clin Chim Acta. 2018;486:209–213. [DOI] [PubMed] [Google Scholar]
  • 21.Holay MP, Paunikar NP, Joshi PP, Sahasrabhojney VS, Tankhiwale SR. Effect of passive smoking on endothelial function in: healthy adults. J Assoc Physicians India. 2004;52:114–117. [PubMed] [Google Scholar]
  • 22.Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008;6(6):883–895. [DOI] [PubMed] [Google Scholar]
  • 23.Ittner C, Burek M, Störk S, Nagai M, Förster CY. Increased Catecholamine Levels and Inflammatory Mediators Alter Barrier Properties of Brain Microvascular Endothelial Cells in vitro. Frontiers in Cardiovascular Medicine. 2020;7(73). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mason J, Wheeler W, Brown MJ. The economic burden of exposure to secondhand smoke for child and adult never smokers residing in U.S. public housing. Public Health Rep. 2015;130(3):230–244. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES